Amyotrophic Lateral Sclerosis: An Emerging Era of Collaborative Gene Discovery

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). It is currently incurable and treatment is largely limited to supportive care. Family history is associated with an increased risk of ALS, and many Mendelian causes have been discovered. However, most forms of the disease are not obviously familial. Recent advances in human genetics have enabled genome-wide analyses of single nucleotide polymorphisms (SNPs) that make it possible to study complex genetic contributions to human disease. Genome-wide SNP analyses require a large sample size and thus depend upon collaborative efforts to collect and manage the biological samples and corresponding data. Public availability of biological samples (such as DNA), phenotypic and genotypic data further enhances research endeavors. Here we discuss a large collaboration among academic investigators, government, and non-government organizations which has created a public repository of human DNA, immortalized cell lines, and clinical data to further gene discovery in ALS. This resource currently maintains samples and associated phenotypic data from 2332 MND subjects and 4692 controls. This resource should facilitate genetic discoveries which we anticipate will ultimately provide a better understanding of the biological mechanisms of neurodegeneration in ALS.

[1]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[2]  Sonja W. Scholz,et al.  Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data , 2007, The Lancet Neurology.

[3]  Orla Hardiman,et al.  The complex genetics of amyotrophic lateral sclerosis , 2007, The Lancet Neurology.

[4]  D. Thurman,et al.  How common are the “common” neurologic disorders? , 2007, Neurology.

[5]  Sonja W. Scholz,et al.  Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals. , 2007, Human molecular genetics.

[6]  R. Conwit,et al.  Preventing familial ALS: A clinical trial may be feasible but is an efficacy trial warranted? , 2006, Journal of the Neurological Sciences.

[7]  Sonja W. Scholz,et al.  Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.

[8]  Johanna M Seddon,et al.  Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.

[9]  S. Ennis,et al.  ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis , 2006, Nature Genetics.

[10]  P. Kaufmann,et al.  ALS Research Group (ALSRG): Second meeting, a summary report , 2006, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[11]  Lyle J Palmer,et al.  Genetic Epidemiology 4 Shaking the tree : mapping complex disease genes with linkage disequilibrium , 2022 .

[12]  Peter M Andersen,et al.  Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  James Ostell.  Databases of Discovery , 2005, ACM Queue.

[14]  A. Chiò,et al.  Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. , 2005, Brain : a journal of neurology.

[15]  D. Clayton,et al.  Genome-wide association studies: theoretical and practical concerns , 2005, Nature Reviews Genetics.

[16]  S. Ennis,et al.  A novel candidate region for ALS on chromosome 14q11.2 , 2004, Neurology.

[17]  T. Gillingwater,et al.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.

[18]  A. Ludolph,et al.  Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS , 2004, Neurology.

[19]  John W Griffin,et al.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.

[20]  G. Nogales-Gadea,et al.  A novel exon 5 mutation (N139H) in the SOD1 gene in a Spanish family associated with incomplete penetrance , 2004, Journal of the Neurological Sciences.

[21]  A. Kertesz.  A frontotemporal family bridge. , 2004, Archives of neurology.

[22]  M. Weiner,et al.  17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. , 2004, Archives of neurology.

[23]  Toshihiro Tanaka.  The International HapMap Project , 2003, Nature.

[24]  N. Siddique,et al.  A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset, incomplete penetrance and a sensory neuropathy , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[25]  Andrew Fraser.  Worms in L.A. , 2003, Nature Genetics.

[26]  J. Haines,et al.  Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. , 2003, American journal of human genetics.

[27]  Shin J. Oh,et al.  Mutant dynactin in motor neuron disease , 2003, Nature Genetics.

[28]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[29]  M. Vila,et al.  Series Introduction: Neurodegeneration: What is it and where are we? , 2003 .

[30]  Robert H. Brown,et al.  A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. , 2002, American journal of human genetics.

[31]  Harold Varmus,et al.  Genomic empowerment: the importance of public databases , 2002, Nature Genetics.

[32]  Mark A. Levenstien,et al.  Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. , 2001, Molecular genetics and metabolism.

[33]  M Gwinn,et al.  Informed consent for population-based research involving genetics. , 2001, JAMA.

[34]  Jeffrey D. Rothstein,et al.  From charcot to lou gehrig: deciphering selective motor neuron death in als , 2001, Nature Reviews Neuroscience.

[35]  M. Pericak-Vance,et al.  The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis , 2001, Nature Genetics.

[36]  S. Scherer,et al.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.

[37]  K. Abe,et al.  A novel SOD1 gene mutation in familial ALS with low penetrance in females , 2001, Journal of the Neurological Sciences.

[38]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[39]  S. Hadano,et al.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.

[40]  J. Mitchell.  Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) – from diagnosis to patient care , 2000, Journal of Neurology.

[41]  J. Haines,et al.  Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. , 2000, JAMA.

[42]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[43]  M. Swash,et al.  Consensus guidelines for the design and implementation of clinical trials in ALS , 1999, Journal of the Neurological Sciences.

[44]  M. Pericak-Vance,et al.  Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers , 1998, Neurogenetics.

[45]  K. Wilhelmsen,et al.  Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. , 1994, American journal of human genetics.

[46]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[47]  H J Bennett,et al.  How common is common? , 1991, Southern medical journal.

[48]  S. Mellgren,et al.  Familial amyotrophic lateral sclerosis , 1980 .

[49]  G. de‐Thé,et al.  Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord‐blood lymphocytes infected by epstein‐barr virus (EBV) , 1975, International journal of cancer.

[50]  D. E. Szilagyi.  HENRY FORD HOSPITAL. , 1965, Medical times.